Brief of diving:
- Johnson & Johnson has signed an agreement of $ 2 billion To achieve a space in Holly Springs from Fujifilm Biotechnologies, North Carolina, as part of a greater strategy to invest much in the manufacture of the United States in the coming years.
- The ten -year agreement will extend the Biopharma Giant’s manufacturing capacity with a new installation of 160,000 square feet, according to a statement. It will also create 120 jobs in the Raleigh area.
- Investment is part of a larger commitment of $ 55 million to support manufacturing, technology and north -American research and development projects over the next four years. J&J said he plans to share more expansion details in the coming months.
Divide vision:
J&A Regeneron They will be some of the first tenants of the Fujifilm Biotechnologies Holly Springs installation when it opens later this year.
The recent agreement allows J&J to make “the vast majority” of its advanced medicines in the United States to meet national demand, said the new Brunswick, the Jersey -based company. J&J manufactures medicines for oncology, immunology, neuroscience and cardiopulmonary fields, according to their website.
J&J opera 23 North -American Facilities, which includes about a third of its global manufacturing footprint, according to its Annual report 2024. The company has been building its national operations, as the rates complicate international trade and more tax incentives are available to the manufacturers who do business in the United States.
“It’s hard to know what will ultimately happen with the rates,” J&J’s CEO Joaquin Duato said during a July 16 earn call. “But what we know for sure is that the fiscal policies that have just passed are already creating North -American and Innovation Props of Populations.”
The current administration’s tax law improved manufacturers Ability to deduce business expenses For costs related to domestic R&D and some production properties.
Fujifilm Biotechnologies Holly Springs installation will be the largest cell cultivation biopharmaceutical installation in the company Organization of development and manufacture of contracts Manufacture in North America, according to its website. Fujifilm matrix has invested more than 3.2 billion dollars In the project so far, with the plans to bring 1,400 jobs to the area by 2031.
Earlier this year Regeneron, a big bulk medicine manufacturer, had a $ 3 billion offer agreement Fujifilm Biotechnologies that is expected to be almost doubled by the United States’ manufacturing capacity as rates stun global tensions.
Last month, President Donald Trump threatened rates up to 250% to pharmaceutical imports during the coming year and a half. However, this is likely to vary by country. More recently, the US reached an agreement to capture its rates to 15% for EU pharmaceuticals.
In addition to the agreement with Fujifilm Biotechnologies, J&J advances with other North -American projects, including the construction of their Installation of $ 2 million more In Wilson, North Carolina. It is also investing in R&D infrastructure for developing life treatments in oncology, neuroscience and other areas of study, according to a statement on August 21.
